Hydroxychloroquine
Top View
- Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
- Treatment of Q Fever Endocarditis: Comparison of 2 Regimens
- Hydroxychloroquine (All Populations Monograph)
- Hydroxychloroquine and Chloroquine: a Potential and Controversial Treatment for COVID‑19
- Guidelines for Treatment of Malaria in the United States 1 (Based on Drugs Currently Available for Use in the United States — October 1, 2019)
- QUANTITY LIMIT PRIOR AUTHORIZATION CRITERIA BRAND NAME (Generic) (Chloroquine)
- COVID-19 Treatment Guidelines Clinical Management No Specific Treatment for COVID-19 Is Currently Available
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION
- PATIENT FACT SHEET Hydroxychloroquine
- Hydroxychloroquine
- Guidelines for Treatment of Malaria in the United States (Based on Drugs
- A Potential Ethical Dilemma for Rheumatologists During the COVID-19 Pandemic
- Drugs for Parasitic Infections (2013 Edition)
- Chloroquine and Hydroxychloroquine Fact Sheet
- Doxycycline Is a Safe Alternative to Hydroxychloroquine + Azithromycin
- Approaches to Soft Drug Analogues of Dihydrofolate Reductase Inhibitors
- Medicines for the Prevention of Malaria While Traveling Hydroxychloroquine (Plaquenil™)